Literature DB >> 15735893

[Antimicrobial peptides. A perspective for the treatment of chronic wounds?].

A Körber1, S Grabbe, J Dissemond.   

Abstract

Human antimicrobial peptides play a substantial role in the immune response to various dermatological diseases, such as acne, atopic dermatitis and psoriasis vulgaris, and even mucosal HIV-protection is mediated inter alia by antimicrobial peptides. In wound healing, the antimicrobial and immune-modulating properties of, in particular, human defensins and cathelicidins can affect important controlling factors. For example, the interaction between different antimicrobial peptides and growth factors supports neoangiogenesis. Although further clinical investigations are necessary to identify the exact effects of antimicrobial peptides in chronic wounds, such peptides could be a promising therapeutic option in the near future for the treatment of patients with chronic wounds by promoting endogen expression or exogenous supplementation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735893     DOI: 10.1007/s00105-005-0915-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  25 in total

1.  [Modern wound management].

Authors:  R Gillitzer
Journal:  Hautarzt       Date:  2002-02       Impact factor: 0.751

2.  Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin.

Authors:  Masamoto Murakami; Takaaki Ohtake; Robert A Dorschner; Birgit Schittek; Claus Garbe; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2002-11       Impact factor: 8.551

Review 3.  Impact of increasing antimicrobial resistance on wound management.

Authors:  P Margreet G Filius; Inge C Gyssens
Journal:  Am J Clin Dermatol       Date:  2002       Impact factor: 7.403

Review 4.  Defensins: natural anti-HIV peptides.

Authors:  Theresa L Chang; Mary E Klotman
Journal:  AIDS Rev       Date:  2004 Jul-Sep       Impact factor: 2.500

5.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

6.  Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.

Authors:  J Harder; J Bartels; E Christophers; J M Schroder
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

Review 7.  Crohn's disease: a defensin deficiency syndrome?

Authors:  Klaus Fellermann; Jan Wehkamp; Klaus R Herrlinger; Eduard F Stange
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-06       Impact factor: 2.566

8.  Defensins and acne.

Authors:  Michael P Philpott
Journal:  Mol Immunol       Date:  2003-11       Impact factor: 4.407

9.  Human beta-defensin-2 expression is increased in chronic wounds.

Authors:  Janet Butmarc; Tatyana Yufit; Polly Carson; Vincent Falanga
Journal:  Wound Repair Regen       Date:  2004 Jul-Aug       Impact factor: 3.617

Review 10.  [Pathogenetic significance of methicillin resistant Staphylococcus aureus (MRSA) in chronic wounds].

Authors:  J Dissemond; M Goos; S Esser
Journal:  Vasa       Date:  2003-08       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.